AEGON LTD

India Glycols Ltd’s latest disclosures reveal a strategic governance overhaul with Enature Bio Pharma, boosting board expertise to accelerate its inter‑company restructuring and strengthen compliance.

Uncover how Aegon’s 2026 H1 results reveal strong operating growth, capital optimisation and a U.S. HQ shift—plus ESG and CFO risks you can’t miss.